GeminIQ Website Logo

Viewing CNXU free

Subscribe for full history, 90+ metrics, screener, watchlist...

Conexeu Sciences Inc.

CNXU

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-04-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
7
Restricted Cash And Cash Equivalents At Carrying V…
0
Income Taxes Receivable
0
Interest Receivable Current
0
Notes And Loans Receivable Net Current
0
Prepaid Expense Current
1
Assets Current
8
Assets Noncurrent
Deferred Costs
0
Investments
0
Security Deposit
0
Property Plant And Equipment Net
0
Finite Lived Intangible Assets Net
0
Assets
8
Liabilities And Stockhold…
Liabilities
Liabilities Current
Accounts Payable And Accrued Liabilities Current
0
Other Accounts Payable And Accrued Liabilities
0
Employee Related Liabilities Current
0
Liabilities
1
Stockholders Equity
Preferred Stock Value
0
Common Stock Value
0
Additional Paid In Capital
16
Retained Earnings Accumulated Deficit
-9
Stockholders Equity
7
Liabilities And Stockholders Equity
8
Accumulated Depreciation Depletion And Amortizatio…
0
Finite Lived Intangible Assets Accumulated Amortiz…
0
Preferred Stock Par Or Stated Value Per Share
0.001
Preferred Stock Shares Authorized
50
Preferred Stock Shares Issued
0
Preferred Stock Shares Outstanding
0
Common Stock Par Or Stated Value Per Share
0.001
Common Stock Shares Authorized
250
Common Stock Shares Issued
21
Shares Outstanding
21

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q2 1 Month
Q2 2 Month
Q2 3 Month
20263.87%--

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-04-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Calculated Values
Net Debt
-7.30M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-06-18Purchase
Owner: Purcell, Lynn Sebastian
Title: -
Shares: 202,500
Price/Share: $0.80
Value: $162,000.00
Shares Owned: 2,734,240
Relationship: Director,TenPercentOwner
Ownership: Indirect
2026-05-12Purchase
Owner: Purcell, Lynn Sebastian
Title: -
Shares: 422,500
Price/Share: $0.80
Value: $338,000.00
Shares Owned: 2,531,740
Relationship: Director,TenPercentOwner
Ownership: Indirect
2026-05-12Purchase
Owner: Onepointtwo, Capital Vent…
Title: -
Shares: 422,500
Price/Share: $0.80
Value: $338,000.00
Shares Owned: 1,047,500
Relationship: TenPercentOwner
Ownership: Direct

Subscribe to unlock 17+ years of data

No institutional ownership data available.

Conexeu Sciences Inc. (CNXU) — SEC Financial Statements & Analysis

Conexeu Sciences Inc. (CNXU) is a orthopedic, prosthetic & surgical appliances & supplies company, incorporated in NV. Conexeu Sciences Inc. trades on Nasdaq as: CNXU. Figures below are sourced from SEC EDGAR, as-filed.

Frequently Asked Questions

What industry is Conexeu Sciences Inc. in?

Conexeu Sciences Inc. (CNXU) operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry.

What exchange does CNXU trade on?

Conexeu Sciences Inc. (CNXU) trades on the Nasdaq.

Where is Conexeu Sciences Inc. incorporated?

Conexeu Sciences Inc. is incorporated in NV.

Wall Street's data.
Main Street's price.